← FDA Drug Approvals (Drugs@FDA)

LEVOFLOXACIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: WATSON LABS TEVA · Approved 2011-02-10

Drug application

FDA Application #

ANDA076826

Application type

Abbreviated New Drug Application (Generic)

Brand name

LEVOFLOXACIN

Generic name

Levofloxacin

Active ingredients

LEVOFLOXACIN

Dosage form

SOLUTION/DROPS

Route

OPHTHALMIC

Marketing status

Discontinued

Sponsor

WATSON LABS TEVA

First approval

2011-02-10

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown